These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19821491)

  • 21. High-strength resorbable brushite bone cement with controlled drug-releasing capabilities.
    Hofmann MP; Mohammed AR; Perrie Y; Gbureck U; Barralet JE
    Acta Biomater; 2009 Jan; 5(1):43-9. PubMed ID: 18799378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of an effervescent additive as porogenic agent for bone cement macroporosity.
    Hesaraki S; Sharifi D
    Biomed Mater Eng; 2007; 17(1):29-38. PubMed ID: 17264385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel skeletal drug delivery system using a self-setting calcium phosphate cement. 5. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug.
    Otsuka M; Matsuda Y; Suwa Y; Fox JL; Higuchi WI
    J Pharm Sci; 1994 Nov; 83(11):1565-8. PubMed ID: 7891275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinspired organic-inorganic composite materials prepared by an alternate soaking process as a tissue reconstitution matrix.
    Ogomi D; Serizawa T; Akashi M
    J Biomed Mater Res A; 2003 Dec; 67(4):1360-6. PubMed ID: 14624523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel skeletal drug delivery system using self-setting bioactive glass bone cement. IV: Cephalexin release from cement containing polymer-coated bulk powder.
    Otsuka M; Matsuda Y; Kokubo T; Yoshihara S; Nakamura T; Yamamuro T
    Biomed Mater Eng; 1993; 3(4):229-36. PubMed ID: 8205064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion release, porosity, solubility, and bioactivity of MTA Plus tricalcium silicate.
    Gandolfi MG; Siboni F; Primus CM; Prati C
    J Endod; 2014 Oct; 40(10):1632-7. PubMed ID: 25260736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of interconnected macropores in apatitic calcium phosphate bone cement with the use of an effervescent additive.
    Hesaraki S; Moztarzadeh F; Sharifi D
    J Biomed Mater Res A; 2007 Oct; 83(1):80-7. PubMed ID: 17380498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bulk properties and bioactivity assessment of porous polymethylmethacrylate cement loaded with calcium phosphates under simulated physiological conditions.
    Lopez-Heredia MA; Sa Y; Salmon P; de Wijn JR; Wolke JG; Jansen JA
    Acta Biomater; 2012 Aug; 8(8):3120-7. PubMed ID: 22588072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestradiol release from self-setting apatitic bone cement responsive to plasma-calcium level in ovariectomized rats, and its physicochemical mechanism.
    Otsuka M; Yoneoka K; Matsuda Y; Fox JL; Higuchi WI; Sugiyama Y
    J Pharm Pharmacol; 1997 Dec; 49(12):1182-8. PubMed ID: 9466340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sr-substituted hydroxyapatites for osteoporotic bone replacement.
    Landi E; Tampieri A; Celotti G; Sprio S; Sandri M; Logroscino G
    Acta Biomater; 2007 Nov; 3(6):961-9. PubMed ID: 17618844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physical properties of apatite bone cement].
    Chen D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Mar; 17(1):13-5, 18. PubMed ID: 10879182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro surface reaction layer formation and dissolution of calcium phosphate cement-bioactive glass composites.
    Liu C; Chen CW; Ducheyne P
    Biomed Mater; 2008 Sep; 3(3):034111. PubMed ID: 18689928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porous polymer/bioactive glass composites for soft-to-hard tissue interfaces.
    Zhang K; Ma Y; Francis LF
    J Biomed Mater Res; 2002 Sep; 61(4):551-63. PubMed ID: 12115445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the Surface Acidity of the Alumina on the Sustained Release of Ketoprofen.
    San Roman S; Gullón J; Del Arco M; Martín C
    J Pharm Sci; 2016 Jul; 105(7):2146-54. PubMed ID: 27287518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of a nanocrystalline apatite reinforced crosslinked hyaluronic acid-tyramine composite as an injectable bone cement.
    Pek YS; Kurisawa M; Gao S; Chung JE; Ying JY
    Biomaterials; 2009 Feb; 30(5):822-8. PubMed ID: 19027947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural study of mineralization of a strontium-containing hydroxyapatite (Sr-HA) cement in vivo.
    Wong CT; Chen QZ; Lu WW; Leong JC; Chan WK; Cheung KM; Luk KD
    J Biomed Mater Res A; 2004 Sep; 70(3):428-35. PubMed ID: 15293316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced apatite-forming ability and antibacterial activity of porous anodic alumina embedded with CaO-SiO2-Ag2O bioactive materials.
    Ni S; Li X; Yang P; Ni S; Hong F; Webster TJ
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():700-8. PubMed ID: 26478362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride.
    Jiang PJ; Patel S; Gbureck U; Caley R; Grover LM
    J Biomed Mater Res B Appl Biomater; 2010 Apr; 93(1):51-8. PubMed ID: 20024966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
    Prokopowicz M
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Composition-controlled nanocomposites of apatite and collagen incorporating silicon as an osseopromotive agent.
    Lynn AK; Nakamura T; Patel N; Porter AE; Renouf AC; Laity PR; Best SM; Cameron RE; Shimizu Y; Bonfield W
    J Biomed Mater Res A; 2005 Sep; 74(3):447-53. PubMed ID: 15983990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.